Semax, a synthetic peptide developed in Russia, mimics adrenocorticotropic hormone (ACTH) without affecting hormonal balance. It enhances cognitive function, improves memory, and promotes neurogenesis. Clinically, it treats stroke, brain injuries, and optic nerve disease by modulating BDNF and neurotransmitters.
Cerebrolysin is a neuropeptide drug derived from pig brain proteins that mimics nerve growth factors. Used primarily in neurological conditions like Alzheimer’s, strokes, and traumatic brain injuries, it promotes synaptic plasticity and neuron protection. Clinical trials suggest cognitive improvements, but ongoing research continues to explore its efficacy.
Peptides, short chains of amino acids, are being explored as a treatment for ADHD. Research focuses on their ability to modulate neurotransmitter systems, aiding attention and impulse control. Unlike stimulants, peptides offer targeted treatment with fewer side effects. While in early research stages, they may complement or replace conventional treatments, pending further studies on efficacy and safety.
.jpg_10.jpeg "Peptides Emerging as a Promising Treatment for ADHD")
